Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Antios Therapeutics
Biotech
The 2023 Biotech Graveyard
Nearly four times as many companies entered the biotech graveyard in 2023 compared to 2022.
Max Bayer
,
Gabrielle Masson
Oct 31, 2023 6:00am
Hep B biotech Antios closed after FDA hold proved insurmountable
Sep 22, 2023 11:23am
Assembly's line of core inhibitors wobbles on the conveyor belt
Apr 19, 2023 10:15am
Antios hep B drug slows viral rebound, but FDA hold casts shadow
Jun 27, 2022 11:41am
Antios rocked as hepatitis B safety signal sparks clinical hold
May 25, 2022 8:42am
Antios raises a further $75M to fuel pursuit of hepatitis B cure
Nov 3, 2021 9:15am